"The Centers for Medicare & Medicaid Services finalized a 2.48% payment increase for 2027 Medicare Advantage plans, coming in above the high end of the 1% to 2% improvement versus the proposal that the market was expecting."
"UnitedHealth Group is well-positioned to benefit from this rate increase due to its scale and integrated Optum platform, despite facing near-term membership declines in pursuit of profitability."
"Today's CMS decision changes the calculus. The company guided for 2026 revenue above $439 billion and adjusted EPS above $17.75, and a cleaner reimbursement environment gives those targets more credibility."
UnitedHealth Group's stock rose nearly 11% due to a better-than-expected CMS Medicare Advantage rate decision, which finalized a 2.48% payment increase for 2027 plans. This increase exceeds market expectations and projects over $13 billion in additional payments. The decision provides a much-needed margin recovery for the managed care sector, which had been under pressure. UnitedHealth is positioned to benefit from this rate increase, despite facing near-term challenges. Bank of America raised its price target for UNH stock, reflecting a more positive outlook.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]